Benjamin Graham · Inversión deep-value defensiva
Is Regeneron Pharmaceuticals, Inc. (REGN) a Benjamin Graham Stock?
Meets 3/7 Graham criteria, partially qualifies.
66/100
Mixto
3/7 criterios cumplidos
Los criterios de Benjamin Graham, aplicados a REGN
P/E ≤ 15
clave16.4x
P/B ≤ 1.5
clave2.3x
Current ratio ≥ 2
3.6x
Debt / Equity ≤ 1
0.1x
Cómo se valora REGN en otras estrategias
Datos financieros en vivo
Cap. mercado
$74.79B
PER (TTM)
16.4x
ROIC (TTM)
8.53%
Margen bruto
84.55%
Otros análisis Benjamin Graham
Preguntas frecuentes
What is REGN's Benjamin Graham fit score?
REGN scores 66/100 on our Benjamin Graham fit engine. Meets 3/7 Graham criteria, partially qualifies.
Does Benjamin Graham actually own REGN?
Our score is computed from financial fundamentals against Benjamin Graham's published criteria. We don't claim that Benjamin Graham personally owns or recommends REGN.
How often is this score updated?
REGN's Benjamin Graham fit score is recomputed daily from the latest TTM financials. The page below shows when it was last refreshed.
Herramienta educativa, no es asesoramiento financiero. Las puntuaciones se calculan a partir de datos financieros públicos contra los criterios publicados de cada estrategia de inversión. No afirmamos que Benjamin Graham posea o recomiende REGN personalmente.
